News

For the fifth year in a row, we had the pleasure of participating in the Annual Meeting of the Working Group for Dermatohistology (ADH). This year’s 33rd edition in Münster was a special one for us: as a Gold Sponsor, we welcomed visitors at our largest booth yet—and somehow, it still felt like we could have used even more space.

The joint project BESTFIT was presented to the public for the first time at the kick-off meeting “AI-supported Precision Surgery in Oncology” (KIOn) organized by the German Federal Ministry of Research, Technology and Space (BMFTR) in Berlin. The aim of the collaborative project is to significantly improve therapy planning and treatment of head and neck…

On January 14, 2026, aisencia and HpH Institute of Pathology and Hematopathology Hamburg entered into a comprehensive development partnership.

Our team has successfully implemented Vistaneos, our innovative Laboratory Information System (LIS), at Dermatologikum Hamburg, one of Germany’s leading dermatopathology institutes.

As part of the AI-Path project, aisencia GmbH and the Digital Media Lab at the University of Bremen are joining forces to redefine how pathologists work in the digital age.

aisencia GmbH has been awarded €150,000 in EU funding through the BRE-Up program to further develop its digital, AI-powered software solutions Vistaneos and Cutaneos 80.

We are extremely proud to welcome Pathscan Pty Ltd. from Australia as a strategic partner and investor—alongside industry leaders Dr. Ian Katz and Paul Richard.

We are thrilled to announce an strategic partnership with PathPresenter. This collaboration marks a significant milestone by expanding our offerings to the US market.

This innovative product integrates a laboratory information system, an image management system, and DermPath AI, enabling a seamlessly optimized laboratory workflow.

On October 30-31, 2024, Berlin hosted the Stage Two finals, where aisencia® spectacularly earned double recognition from both b2venture and xdeck, who were impressed by our technology.